SoftBank in investment talks with Chinese mRNA vaccine firm Abogen - sources
Chinese mRNA vaccine developer Suzhou Abogen Biosciences is in talks with Japans SoftBank and other investors to raise $300 million-$400 million, people familiar with the matter said. ... | November 26, 2021
Source: marketscreener.com